16333-93-0

Basic information

• Product Name: 1-(Aminomethyl)-3-methylenecyclobutane 97%
• Synonyms: 1-(Aminomethyl)-3-methylenecyclobutane 97%;1-(Aminomethyl)-3-methylidenecyclobutane , (3-Methylenecyclobut-1-yl)methylamine, (3-Methylidenecyclobut-1-yl)methylamine;3-Methylene-cyclobutanemethanamine;1-(Aminomethyl)-3-methylenecyclobutane;1-(Aminomethyl)-3-methylenecyclobutane97%
• CAS NO: 16333-93-0
• Molecular Formula: C₆H₁₁N
• Molecular Weight: 97
• Mol File: 16333-93-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(Aminomethyl)-3-methylenecyclobutane 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Aminomethyl)-3-methylenecyclobutane 97%(16333-93-0)
• EPA Substance Registry System: 1-(Aminomethyl)-3-methylenecyclobutane 97%(16333-93-0)

Safety Data

• Hazardous Substances Data: 16333-93-0(Hazardous Substances Data)

Usage

Purity

97%

Chemical Structure

A cyclobutane derivative with a methyl group and an aminomethyl group attached to the same carbon atom.

Potential Applications

Organic synthesis
Pharmaceutical research

Utilization

Development of new compounds
Development of new drugs

Suitability

Laboratory settings
Industrial settings

Advantages

Precise and reproducible results
High purity

Reactivity

Unique structure and reactivity can be utilized in various chemical reactions and processes.

Value

Valuable chemical with diverse potential applications.

Upstream product

• 15760-35-7 3-methylenecyclobutanecarbonitrile 

Downstream Products

• 1420294-67-2 benzyl 3-methylenecyclobutylmethylcarbamate 
• 1420294-70-7 Benzyl (5,5-dichloro-6-oxospiro[3.3]heptan-2-yl)methylcarbamate 
• 1420294-72-9 Benzyl (6-oxospiro[3.3]heptan-2-yl)methylcarbamate 

Relevant articles and documents

9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUND

The present invention relates to 9-aminomethyl substituted tetracycline compounds represented by formula (I), or pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as well as a method for preparing these compounds and a pharmaceutical composition comprising the same. The present invention relates also to a use of these compounds in the preparation of a medicament for the treatment and/or prophylaxis of tetracycline drug-sensitive disease. wherein, R2a, R2b, R3, R4a, R4b, R5, R6a, R6b, R7, R8, R9a, R9b, R10, R11, R12, R13a and R13b are each independently as defined in the description.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q5, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (Formula (I)), including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.